Veterinary Medicines

Pyrocam 15 mg/ml oral suspension for pigs

Authorised
  • Meloxicam
Download as PDF

Product identification

Medicine name:
Pyrocam 15 mg/ml oral suspension for pigs
Pyrocam 15 mg/ml suspensie voor oraal gebruik voor varkens
Pyrocam 15 mg/ml suspension buvable pour porcins
Pyrocam 15 mg/ml Suspension zum Eingeben für Schweine
Active substance:
  • Meloxicam
Target species:
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Meloxicam
    15.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AC06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Cardboard box with HDPE bottle of 1000 ml closed with a two-part tamper evident closure consisting of an outer white cap (PP), an internal natural colour screw closure (HDPE) and a mounted plug (LDPE) + plastic measuring syringe
  • Cardboard box with HDPE bottle of 250 ml closed with a two-part tamper evident closure consisting of an outer white cap (PP), an internal natural colour screw closure (HDPE) and a mounted plug (LDPE) + plastic measuring syringe
  • Cardboard box with HDPE bottle of 125 ml closed with a two-part tamper evident closure consisting of an outer white cap (PP), an internal natural colour screw closure (HDPE) and a mounted plug (LDPE) + plastic measuring syringe

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet J.S.C.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V661874
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0048/001
Concerned member states:
  • Austria
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 31/01/2024
Download
French (PDF)
Published on: 31/01/2024
Download
German (PDF)
Published on: 31/01/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 31/01/2024
Download
French (PDF)
Published on: 31/01/2024
Download
German (PDF)
Published on: 31/01/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 31/01/2024
Download
French (PDF)
Published on: 31/01/2024
Download
German (PDF)
Published on: 31/01/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."